- Home
- LHX vs ALC Comparison
LHX vs ALC Comparison
Compare LHX & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LHX
- ALC
- Stock Information
- Founded
- LHX 1895
- ALC 1945
- Country
- LHX United States
- ALC Switzerland
- Employees
- LHX N/A
- ALC N/A
- Industry
- LHX Industrial Machinery/Components
- ALC Ophthalmic Goods
- Sector
- LHX Industrials
- ALC Health Care
- Exchange
- LHX Nasdaq
- ALC Nasdaq
- Market Cap
- LHX 51.9B
- ALC 40.2B
- IPO Year
- LHX N/A
- ALC N/A
- Fundamental
- Price
- LHX $281.88
- ALC $77.55
- Analyst Decision
- LHX Buy
- ALC Buy
- Analyst Count
- LHX 18
- ALC 10
- Target Price
- LHX $278.94
- ALC $96.73
- AVG Volume (30 Days)
- LHX 1.0M
- ALC 2.6M
- Earning Date
- LHX 10-23-2025
- ALC 11-11-2025
- Dividend Yield
- LHX 1.72%
- ALC 0.28%
- EPS Growth
- LHX 43.44
- ALC N/A
- EPS
- LHX 8.95
- ALC 2.16
- Revenue
- LHX $21,373,000,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- LHX $3.09
- ALC $6.21
- Revenue Next Year
- LHX $5.78
- ALC $7.51
- P/E Ratio
- LHX $31.19
- ALC $36.22
- Revenue Growth
- LHX 2.93
- ALC 4.04
- 52 Week Low
- LHX $193.09
- ALC $77.44
- 52 Week High
- LHX $281.68
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- LHX 65.38
- ALC 37.48
- Support Level
- LHX $268.60
- ALC $77.44
- Resistance Level
- LHX $274.70
- ALC $80.91
- Average True Range (ATR)
- LHX 3.89
- ALC 1.17
- MACD
- LHX 0.27
- ALC -0.00
- Stochastic Oscillator
- LHX 97.50
- ALC 2.51
About LHX L3Harris Technologies Inc.
In addition to its legacy software-defined radio franchise, L3Harris Technologies has through a series of acquisitions established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It also adapts civilian aircraft for military use and provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.